Neuro-therapy (uk) Ltd

POWER SEARCH PRICING

SOLUTIONS

neuro-therapy (uk) ltd Company Information

Live

EstablishedMicroLow

Company Number

06160018

Next Accounts

Dec 2025

Industry

Specialist medical practice activities

Directors

Helen Edwards

Jane Creed

Shareholders

helen marie edwards

jane creed

Group Structure

View All

Contact

Registered Address

gainsborough hill farm house, chester road, walsall, WS9 9HH

Website

http://neuro-therapy.co.uk

neuro-therapy (uk) ltd Estimated Valuation

£261.1k

Pomanda estimates the enterprise value of NEURO-THERAPY (UK) LTD at £261.1k based on a Turnover of £463.1k and 0.56x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Neuro-therapy (uk) Ltd is a live company located in walsall, WS9 9HH with a Companies House number of 06160018. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in March 2007, it's largest shareholder is helen marie edwards with a 50% stake. Neuro-therapy (uk) Ltd is a established, micro sized company, Pomanda has estimated its turnover at £463.1k with low growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Neuro-Therapy (Uk) Ltd a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 7 areas for improvement. Company Health Check FAQs

Health Rating1.5out of 5

0 Strong

4 Regular

7 Weak

Size

annual sales of £463.1k, make it in line with the average company (£413.2k)

Growth

3 year (CAGR) sales growth of 3%, show it is growing at a slower rate (7.6%)

EXPORT

Neuro-Therapy (Uk) Ltd's latest turnover from March 2024 is estimated at £463.1 thousand and the company has net assets of £62.5 thousand. According to their latest financial statements, Neuro-Therapy (Uk) Ltd has 7 employees and maintains cash reserves of £38 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012
Turnover	463,100	425,559	439,525	423,117	484,965	420,514	374,617	446,406	453,834	401,139	396,495	341,292	347,380
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	213,085	190,174	176,871	188,039	186,315	158,271	121,376	125,150	146,180	118,672	100,873	76,352	95,117
Gross Profit	250,015	235,385	262,654	235,078	298,650	262,244	253,242	321,255	307,654	282,466	295,623	264,940	252,263
Admin Expenses	284,695	243,691	257,128	234,505	293,347	252,743	237,648	270,494	322,031	250,501	288,183	266,154	235,693
Operating Profit	-34,680	-8,306	5,526	573	5,303	9,501	15,594	50,761	-14,377	31,965	7,440	-1,214	16,570
Interest Payable	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Receivable	2,901	3,047	529	65	61	486	270	88	157	132	105	103	45
Pre-Tax Profit	-31,779	-5,259	6,056	638	5,364	9,988	15,864	50,849	-14,220	32,097	7,545	-1,111	16,615
Tax	0	0	-1,151	-121	-1,019	-1,898	-3,014	-10,170	0	-6,740	-1,735	0	-4,320
Profit After Tax	-31,779	-5,259	4,905	517	4,345	8,090	12,850	40,679	-14,220	25,357	5,810	-1,111	12,295
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	-31,779	-5,259	4,905	517	4,345	8,090	12,850	40,679	-14,220	25,357	5,810	-1,111	12,295
Employee Costs	212,059	206,157	162,624	211,624	206,130	211,733	196,591	246,887	208,020	241,231	240,842	230,642	213,095
Number Of Employees	7	7	6	8	8	8	8	9	7	8	8	8	8
EBITDA*	-31,877	-5,132	8,547	3,252	7,895	11,827	18,132	53,442	-12,345	33,794	9,315	585	18,259

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012
Tangible Assets	3,343	4,457	3,994	2,968	2,711	1,910	2,547	2,976	1,027	420	560	328	0
Intangible Assets	11,828	13,517	15,206	16,895	18,584	20,273	21,962	23,651	25,340	27,029	28,718	30,407	32,096
Investments & Other	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	15,171	17,974	19,200	19,863	21,295	22,183	24,509	26,627	26,367	27,449	29,278	30,735	32,096
Stock & work in progress	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Debtors	56,389	44,301	52,315	46,701	55,516	49,780	43,566	46,836	52,015	36,159	35,028	26,064	27,081
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	2,359	1,152	196	0	0	0	0	2,000	0	0	0	0	0
Cash	37,992	72,508	70,891	70,262	60,084	62,678	66,982	41,171	28,863	33,888	19,048	23,005	17,999
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	96,740	117,961	123,402	116,963	115,600	112,458	110,548	90,007	80,878	70,047	54,076	49,069	45,080
total assets	111,911	135,935	142,602	136,826	136,895	134,641	135,057	116,634	107,245	97,496	83,354	79,804	77,176
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	15,679	16,047	16,348	13,496	10,563	13,774	12,185	12,726	14,331	55,143	66,358	68,618	64,879
Group/Directors Accounts	0	0	0	0	0	0	12,000	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	33,751	25,628	26,735	28,716	32,235	31,115	29,210	35,096	64,781	0	0	0	0
total current liabilities	49,430	41,675	43,083	42,212	42,798	44,889	53,395	47,822	79,112	55,143	66,358	68,618	64,879
loans	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0
provisions	0	0	0	0	0	0	0	0	0	0	0	0	0
total long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0
total liabilities	49,430	41,675	43,083	42,212	42,798	44,889	53,395	47,822	79,112	55,143	66,358	68,618	64,879
net assets	62,481	94,260	99,519	94,614	94,097	89,752	81,662	68,812	28,133	42,353	16,996	11,186	12,297
total shareholders funds	62,481	94,260	99,519	94,614	94,097	89,752	81,662	68,812	28,133	42,353	16,996	11,186	12,297

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Operating Activities
Operating Profit	-34,680	-8,306	5,526	573	5,303	9,501	15,594	50,761	-14,377	31,965	7,440	-1,214	16,570	0	0
Depreciation	1,114	1,485	1,332	990	903	637	849	992	343	140	186	110	0	0	0
Amortisation	1,689	1,689	1,689	1,689	1,689	1,689	1,689	1,689	1,689	1,689	1,689	1,689	1,689	0	0
Tax	0	0	-1,151	-121	-1,019	-1,898	-3,014	-10,170	0	-6,740	-1,735	0	-4,320	0	0
Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors	13,295	-7,058	5,810	-8,815	5,736	6,214	-5,270	-3,179	15,856	1,131	8,964	-1,017	27,081	0	0
Creditors	-368	-301	2,852	2,933	-3,211	1,589	-541	-1,605	-40,812	-11,215	-2,260	3,739	64,879	0	0
Accruals and Deferred Income	8,123	-1,107	-1,981	-3,519	1,120	1,905	-5,886	-29,685	64,781	0	0	0	0	0	0
Deferred Taxes & Provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	-37,417	518	2,457	11,360	-951	7,209	13,961	15,161	-4,232	14,708	-3,644	5,341	51,737	0	0
Investing Activities
capital expenditure	0	-1,948	-2,358	-1,247	-1,704	0	-420	-2,941	-950	0	-418	-438	-33,785	0	0
Change in Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	0	-1,948	-2,358	-1,247	-1,704	0	-420	-2,941	-950	0	-418	-438	-33,785	0	0
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	-12,000	12,000	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
share issue	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0
interest	2,901	3,047	529	65	61	486	270	88	157	132	105	103	45	0	0
cash flow from financing	2,901	3,047	529	65	61	-11,514	12,270	88	157	132	105	103	47	0	0
cash and cash equivalents
cash	-34,516	1,617	629	10,178	-2,594	-4,304	25,811	12,308	-5,025	14,840	-3,957	5,006	17,999	0	0
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	-34,516	1,617	629	10,178	-2,594	-4,304	25,811	12,308	-5,025	14,840	-3,957	5,006	17,999	0	0

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for neuro-therapy (uk) ltd. Get real-time insights into neuro-therapy (uk) ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for neuro-therapy (uk) ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in WS9 area or any other competitors across 12 key performance metrics.

NEURO-THERAPY (UK) LTD group structure

Neuro-Therapy (Uk) Ltd has no subsidiary companies.

Ultimate parent company

NEURO-THERAPY (UK) LTD

06160018

NEURO-THERAPY (UK) LTD Shareholders

helen marie edwards	50%
jane creed	50%

Neuro-Therapy (Uk) Ltd currently has 2 directors. The longest serving directors include Ms Helen Edwards (Mar 2007) and Ms Jane Creed (Mar 2007).

officer	country	age	start	end	role
Ms Helen Edwards	England	48 years	Mar 2007	-	Director
Ms Jane Creed		56 years	Mar 2007	-	Director

P&L

March 2024

turnover

463.1k

+9%

operating profit

-34.7k

gross margin

54%

-2.39%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

62.5k

-0.34%

total assets

111.9k

-0.18%

cash

38k

-0.48%

net assets

Total assets minus all liabilities

Similar Companies

hpb medical ltd

taha investment limited

strensham hill holdings ltd

fit4tasks occupational health limited

uk imaging ltd

4.5

company number

06160018

Type

Private limited with Share Capital

industry

86220 - Specialist medical practice activities

incorporation date

March 2007

ultimate parent company

None

previous names

N/A

address

gainsborough hill farm house, chester road, walsall, WS9 9HH

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to neuro-therapy (uk) ltd.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for NEURO-THERAPY (UK) LTD. This can take several minutes, an email will notify you when this has completed.

neuro-therapy (uk) ltd Company Information

neuro-therapy (uk) ltd Estimated Valuation

neuro-therapy (uk) ltd Estimated Valuation

neuro-therapy (uk) ltd Estimated Valuation

Neuro-therapy (uk) Ltd Overview

Neuro-therapy (uk) Ltd Health Check

NEURO-THERAPY (UK) LTD financials

neuro-therapy (uk) ltd Credit Report and Business Information

Neuro-therapy (uk) Ltd Competitor Analysis

neuro-therapy (uk) ltd Ownership

neuro-therapy (uk) ltd directors

neuro-therapy (uk) ltd company details

neuro-therapy (uk) ltd Charges & Mortgages

neuro-therapy (uk) ltd Capital Raised & Share Issues BETA

neuro-therapy (uk) ltd Companies House Filings - See Documents